Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25


Towards understanding global patterns of antimicrobial use and resistance in neonatal sepsis: insights from the NeoAMR network.

Li G, Bielicki JA, Ahmed ASMNU, Islam MS, Berezin EN, Gallacci CB, Guinsburg R, da Silva Figueiredo CE, Santarone Vieira R, Silva AR, Teixeira C, Turner P, Nhan L, Orrego J, Pérez PM, Qi L, Papaevangelou V, Triantafyllidou P, Iosifidis E, Roilides E, Sarafidis K, Jinka DR, Nayakanti RR, Kumar P, Gautam V, Prakash V, Seeralar A, Murki S, Kandraju H, Singh S, Kumar A, Lewis L, Pukayastha J, Nangia S, K N Y, Chaurasia S, Chellani H, Obaro S, Dramowski A, Bekker A, Whitelaw A, Thomas R, Velaphi SC, Ballot DE, Nana T, Reubenson G, Fredericks J, Anugulruengkitt S, Sirisub A, Wong P, Lochindarat S, Boonkasidecha S, Preedisripipat K, Cressey TR, Paopongsawan P, Lumbiganon P, Pongpanut D, Sukrakanchana PO, Musoke P, Olson L, Larsson M, Heath PT, Sharland M.

Arch Dis Child. 2019 Aug 24. pii: archdischild-2019-316816. doi: 10.1136/archdischild-2019-316816. [Epub ahead of print]


Dose evaluation of intravenous metamizole (dipyrone) in infants and children: a prospective population pharmacokinetic study.

Ziesenitz VC, Rodieux F, Atkinson A, Borter C, Bielicki JA, Haschke M, Duthaler U, Bachmann F, Erb TO, Gürtler N, Holland-Cunz S, van den Anker JN, Gotta V, Pfister M.

Eur J Clin Pharmacol. 2019 Aug 7. doi: 10.1007/s00228-019-02720-2. [Epub ahead of print]


Mycoplasma pneumoniae detection in children with respiratory tract infections and influence on management - a retrospective cohort study in Switzerland.

Dierig A, Hirsch HH, Decker ML, Bielicki JA, Heininger U, Ritz N.

Acta Paediatr. 2019 Jun 5. doi: 10.1111/apa.14891. [Epub ahead of print]


Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT).

Lyttle MD, Bielicki JA, Barratt S, Dunn D, Finn A, Harper L, Jackson P, Powell CVE, Roland D, Stohr W, Sturgeon K, Wan M, Little P, Faust SN, Robotham J, Hay AD, Gibb DM, Sharland M; PERUKI, GAPRUKI and the CAP-IT trial team.

BMJ Open. 2019 May 22;9(5):e029875. doi: 10.1136/bmjopen-2019-029875.


Estimating global trends in total and childhood antibiotic consumption, 2011-2015.

Jackson C, Hsia Y, Bielicki JA, Ellis S, Stephens P, Wong ICK, Sharland M.

BMJ Glob Health. 2019 Feb 27;4(1):e001241. doi: 10.1136/bmjgh-2018-001241. eCollection 2019.


Consumption of oral antibiotic formulations for young children according to the WHO Access, Watch, Reserve (AWaRe) antibiotic groups: an analysis of sales data from 70 middle-income and high-income countries.

Hsia Y, Sharland M, Jackson C, Wong ICK, Magrini N, Bielicki JA.

Lancet Infect Dis. 2019 Jan;19(1):67-75. doi: 10.1016/S1473-3099(18)30547-4. Epub 2018 Dec 3.


Key Components for Antibiotic Dose Optimization of Sepsis in Neonates and Infants.

van Donge T, Bielicki JA, van den Anker J, Pfister M.

Front Pediatr. 2018 Oct 29;6:325. doi: 10.3389/fped.2018.00325. eCollection 2018. Review.


Using risk adjustment to improve the interpretation of global inpatient pediatric antibiotic prescribing.

Bielicki JA, Sharland M, Versporten A, Goossens H, Cromwell DA.

PLoS One. 2018 Jul 6;13(7):e0199878. doi: 10.1371/journal.pone.0199878. eCollection 2018.


Global shortage of neonatal and paediatric antibiotic trials: rapid review.

Thompson G, Barker CI, Folgori L, Bielicki JA, Bradley JS, Lutsar I, Sharland M.

BMJ Open. 2017 Oct 13;7(10):e016293. doi: 10.1136/bmjopen-2017-016293. Review.


Tackling antimicrobial resistance in neonatal sepsis.

Folgori L, Ellis SJ, Bielicki JA, Heath PT, Sharland M, Balasegaram M.

Lancet Glob Health. 2017 Nov;5(11):e1066-e1068. doi: 10.1016/S2214-109X(17)30362-5. No abstract available.


Fluctuation Metrics as Novel Endpoints for Clinical Trials in Asthma.

Frey U, Bielicki JA.

Am J Respir Crit Care Med. 2017 Apr 15;195(8):967-968. doi: 10.1164/rccm.201611-2286ED. No abstract available.


Surveillance of Gram-negative bacteria: impact of variation in current European laboratory reporting practice on apparent multidrug resistance prevalence in paediatric bloodstream isolates.

Bielicki JA, Cromwell DA, Johnson A, Planche T, Sharland M; ARPEC project.

Eur J Clin Microbiol Infect Dis. 2017 May;36(5):839-846. doi: 10.1007/s10096-016-2869-4. Epub 2016 Dec 26.


Fifteen-minute consultation: the complexities of empirical antibiotic selection for serious bacterial infections-a practical approach.

Bielicki JA, Cromwell DA, Sharland M.

Arch Dis Child Educ Pract Ed. 2017 Jun;102(3):117-123. doi: 10.1136/archdischild-2016-310527. Epub 2016 Nov 22.


Using a simple point-prevalence survey to define appropriate antibiotic prescribing in hospitalised children across the UK.

Gharbi M, Doerholt K, Vergnano S, Bielicki JA, Paulus S, Menson E, Riordan A, Lyall H, Patel SV, Bernatoniene J, Versporten A, Heginbothom M, Goossens H, Sharland M; ARPEC project Group members.

BMJ Open. 2016 Nov 3;6(11):e012675. doi: 10.1136/bmjopen-2016-012675.


Outbreak investigation for toxigenic Corynebacterium diphtheriae wound infections in refugees from Northeast Africa and Syria in Switzerland and Germany by whole genome sequencing.

Meinel DM, Kuehl R, Zbinden R, Boskova V, Garzoni C, Fadini D, Dolina M, Blümel B, Weibel T, Tschudin-Sutter S, Widmer AF, Bielicki JA, Dierig A, Heininger U, Konrad R, Berger A, Hinic V, Goldenberger D, Blaich A, Stadler T, Battegay M, Sing A, Egli A.

Clin Microbiol Infect. 2016 Dec;22(12):1003.e1-1003.e8. doi: 10.1016/j.cmi.2016.08.010. Epub 2016 Aug 30.


Antibiotic preferences for childhood pneumonia vary by physician type and European region.

Bielicki JA, Barker CI, van der Velden AW, Sharland M, van Esso D, Hadjipanayis A, Del Torso S, Grossman Z.

ERJ Open Res. 2016 Apr 29;2(2). pii: 00001-2016. eCollection 2016 Apr.


Reply to: 'Guidelines on prevention of healthcare-associated infection in neonates and children'.

Araujo da Silva AR, Zingg W, Dramowski A, Bielicki JA, Sharland M.

J Hosp Infect. 2016 Nov;94(3):257-258. doi: 10.1016/j.jhin.2016.09.006. Epub 2016 Sep 16. No abstract available.


Ebola Virus Disease in Children, Sierra Leone, 2014-2015.

Fitzgerald F, Naveed A, Wing K, Gbessay M, Ross JC, Checchi F, Youkee D, Jalloh MB, Baion D, Mustapha A, Jah H, Lako S, Oza S, Boufkhed S, Feury R, Bielicki JA, Gibb DM, Klein N, Sahr F, Yeung S.

Emerg Infect Dis. 2016 Oct;22(10):1769-77. doi: 10.3201/eid2210.160579.


Appropriate surveillance methodology for assessing childhood antibiotic resistance: where do we stand?

Bielicki JA, Heath PT, Sharland M.

Future Microbiol. 2016 Sep;11:1109-12. doi: 10.2217/fmb-2016-0134. Epub 2016 Aug 22. No abstract available.


Most international guidelines on prevention of healthcare-associated infection lack comprehensive recommendations for neonates and children.

Araujo da Silva AR, Zingg W, Dramowski A, Bielicki JA, Sharland M.

J Hosp Infect. 2016 Oct;94(2):159-62. doi: 10.1016/j.jhin.2016.05.008. Epub 2016 May 24.


Selecting appropriate empirical antibiotic regimens for paediatric bloodstream infections: application of a Bayesian decision model to local and pooled antimicrobial resistance surveillance data.

Bielicki JA, Sharland M, Johnson AP, Henderson KL, Cromwell DA; Antibiotic Resistance and Prescribing in European Children project.

J Antimicrob Chemother. 2016 Mar;71(3):794-802. doi: 10.1093/jac/dkv397. Epub 2015 Nov 30.


Not too little, not too much: problems of selecting oral antibiotic dose for children.

Bielicki JA, Barker CI, Saxena S, Wong IC, Long PF, Sharland M.

BMJ. 2015 Nov 3;351:h5447. doi: 10.1136/bmj.h5447. No abstract available.


Antibiotic Resistance Prevalence in Routine Bloodstream Isolates from Children's Hospitals Varies Substantially from Adult Surveillance Data in Europe.

Bielicki JA, Lundin R, Sharland M; ARPEC Project.

Pediatr Infect Dis J. 2015 Jul;34(7):734-41. doi: 10.1097/INF.0000000000000652.


In touch but not up-to-date: ambulatory visits and vaccination status in a cohort of young Swiss children.

Bielicki JA, Achermann R, Berger C.

Vaccine. 2013 Nov 4;31(46):5375-80. doi: 10.1016/j.vaccine.2013.09.025. Epub 2013 Sep 26.


Timing of measles immunization and effective population vaccine coverage.

Bielicki JA, Achermann R, Berger C.

Pediatrics. 2012 Sep;130(3):e600-6. doi: 10.1542/peds.2012-0132. Epub 2012 Aug 20.


Supplemental Content

Loading ...
Support Center